ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Selincro®:Lundbeck (Schweiz) AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
N07BB05 - NalmefeneATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N07 - Other Nervous System Drugs

This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.

N07B - Drugs Used in Addictive Disorders

This group comprises drugs used for maintenance treatment of addictive disorders. Drugs used for detoxification are classified in V03A - All other therapeutic products.

N07BB - Drugs Used in Alcohol Dependence

Naltrexone, which is also used in the treatment of opioid dependence, see N07BC, is classified in this group.
Sodium oxybate used in the treatment of alcohol dependence are classified in N07XX - Other nervous system drugs.

The DDD for nalmefene is based on the recommended dose on treatment days.

N07BB05 - Nalmefene
DoseRoute of administrationNote
 O 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home